Clinical Trial

Extended Time Window Intravenous Tenecteplase Thrombolysis Registry for Acute Ischemic Stroke

Study acronym: EXTEND-TNK
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The EXTEND-TNK Registry is a prospective, multicenter, observational cohort study designed to evaluate the effectiveness and safety of intravenous tenecteplase administered beyond 4.5 hours after last known well in patients with acute ischemic stroke (AIS) in routine clinical practice across China.
Trial Details
NCT Number NCT07536165
Lead Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Conditions Stroke, Acute Ischemic Stroke
Enrollment 3,000 participants
Start Date 2026-04
Primary Completion 2028-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-17